ONABOTULINUMTOXINA

ONABOTULINUMTOXINA was reported 77970 times

These side effects are most commonly reported by patients taking ONABOTULINUMTOXINA:

# Side effect Count
0 DRUG INEFFECTIVE 26774
1 OFF LABEL USE 11721
2 THERAPEUTIC RESPONSE DECREASED 4513
3 HEADACHE 4135
4 PRODUCT PREPARATION ERROR 3646
5 INJECTION SITE PAIN 3468
6 EYELID PTOSIS 3149
7 MULTIPLE USE OF SINGLE-USE PRODUCT 2866
8 MIGRAINE 2406
9 NAUSEA 2245
10 PAIN 1921
11 FATIGUE 1878
12 MUSCULAR WEAKNESS 1820
13 DIZZINESS 1813
14 DYSPHAGIA 1731
15 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1722
16 DEATH 1670
17 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1588
18 DYSPNOEA 1561
19 VISION BLURRED 1359
20 ASTHENIA 1287
21 NECK PAIN 1141
22 PRODUCT STORAGE ERROR 1139
23 THERAPEUTIC RESPONSE SHORTENED 1133
24 INJECTION SITE SWELLING 1117
25 RASH 1116
26 SWELLING FACE 1116
27 HYPOAESTHESIA 1098
28 ANXIETY 1041
29 MALAISE 983
30 FACIAL PARESIS 943
31 PARAESTHESIA 915
32 VOMITING 906
33 PRURITUS 898
34 PRODUCT USE IN UNAPPROVED INDICATION 866
35 INFLUENZA LIKE ILLNESS 858
36 FEELING ABNORMAL 847
37 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 835
38 MUSCLE SPASMS 810
39 PRODUCT PREPARATION ISSUE 751
40 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 741
41 URTICARIA 737
42 FALL 736
43 HYPERSENSITIVITY 731
44 DIARRHOEA 728
45 PYREXIA 707
46 HYPERHIDROSIS 703
47 INSOMNIA 688
48 ERYTHEMA 670
49 PRODUCT QUALITY ISSUE 668
50 INJECTION SITE ERYTHEMA 642
51 EYE SWELLING 641
52 ARTHRALGIA 630
53 SWELLING 611
54 WEIGHT DECREASED 599
55 URINARY TRACT INFECTION 589
56 CONTUSION 584
57 VISUAL IMPAIRMENT 583
58 MUSCULOSKELETAL STIFFNESS 568
59 GAIT DISTURBANCE 564
60 PAIN IN EXTREMITY 563
61 ALOPECIA 536
62 BACK PAIN 524
63 DEPRESSION 523
64 DIPLOPIA 522
65 TREMOR 522
66 POOR QUALITY PRODUCT ADMINISTERED 521
67 BURNING SENSATION 516
68 THERAPEUTIC PRODUCT EFFECT DECREASED 516
69 CONDITION AGGRAVATED 514
70 DRY MOUTH 506
71 DRY EYE 498
72 PNEUMONIA 481
73 INJECTION SITE BRUISING 479
74 CONSTIPATION 477
75 SPEECH DISORDER 475
76 DYSPHONIA 467
77 INCORRECT DOSE ADMINISTERED 461
78 MYALGIA 459
79 INJECTION SITE RASH 457
80 BROW PTOSIS 449
81 PALPITATIONS 436
82 DRUG HYPERSENSITIVITY 434
83 SOMNOLENCE 428
84 COUGH 425
85 MEMORY IMPAIRMENT 417
86 SEDATION 415
87 NIGHTMARE 413
88 VERTIGO 412
89 ADVERSE DRUG REACTION 410
90 EYELID OEDEMA 408
91 EYE PAIN 406
92 CHEST PAIN 404
93 BOTULISM 398
94 COVID-19 390
95 CEREBROVASCULAR ACCIDENT 388
96 NEPHROLITHIASIS 374
97 URINARY RETENTION 360
98 SEIZURE 359
99 ABDOMINAL PAIN UPPER 356
100 SINUSITIS 350
101 WEIGHT INCREASED 349
102 FACIAL PARALYSIS 344
103 INJECTION SITE PRURITUS 340
104 SKIN WRINKLING 331
105 BALANCE DISORDER 328
106 DECREASED APPETITE 325
107 LOSS OF CONSCIOUSNESS 323
108 PRODUCT DOSE OMISSION ISSUE 319
109 FACIAL PAIN 318
110 CHEST DISCOMFORT 317
111 NASOPHARYNGITIS 314
112 HYPERTENSION 313
113 OROPHARYNGEAL PAIN 313
114 MUSCLE TWITCHING 307
115 PRODUCT USE ISSUE 307
116 SURGERY 306
117 ACCIDENTAL EXPOSURE TO PRODUCT 303
118 INJECTION SITE MASS 303
119 TINNITUS 302
120 SKIN TIGHTNESS 299
121 DISCOMFORT 298
122 BLOOD PRESSURE INCREASED 295
123 ILLNESS 293
124 HEAD DISCOMFORT 290
125 CONFUSIONAL STATE 283
126 DYSARTHRIA 283
127 INFLUENZA 278
128 ABDOMINAL DISCOMFORT 274
129 INJECTION SITE REACTION 269
130 MUSCLE TIGHTNESS 267
131 GASTROOESOPHAGEAL REFLUX DISEASE 265
132 HEART RATE INCREASED 264
133 CHILLS 263
134 LACRIMATION INCREASED 262
135 PREGNANCY 254
136 OVERDOSE 251
137 INJECTION SITE HAEMORRHAGE 250
138 UNEVALUABLE EVENT 247
139 FACIAL ASYMMETRY 245
140 ABDOMINAL PAIN 243
141 MUSCULOSKELETAL PAIN 243
142 ADVERSE EVENT 241
143 LIP SWELLING 241
144 PERIPHERAL SWELLING 241
145 PHOTOPHOBIA 240
146 MATERNAL EXPOSURE DURING PREGNANCY 238
147 PANIC ATTACK 237
148 THROAT TIGHTNESS 237
149 OCULAR HYPERAEMIA 236
150 FLUSHING 235
151 EYE DISORDER 234
152 SKIN DISORDER 229
153 INJECTION SITE URTICARIA 226
154 ASTHMA 225
155 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 225
156 MOBILITY DECREASED 221
157 PERIORBITAL SWELLING 218
158 PARALYSIS 215
159 URINARY INCONTINENCE 213
160 EYE IRRITATION 212
161 FEELING HOT 211
162 THERAPY NON-RESPONDER 208
163 HOSPITALISATION 205
164 INFECTION 205
165 AMNESIA 203
166 SYNCOPE 201
167 NEURALGIA 195
168 STRESS 195
169 BLEPHAROSPASM 193
170 HYPOTENSION 190
171 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 188
172 HYPOAESTHESIA ORAL 185
173 SUICIDAL IDEATION 185
174 DYSGEUSIA 182
175 MULTIPLE SCLEROSIS 182
176 DRUG INTOLERANCE 180
177 PAIN IN JAW 178
178 THERAPEUTIC RESPONSE UNEXPECTED 174
179 DYSKINESIA 173
180 SKIN DISCOLOURATION 173
181 TREATMENT FAILURE 172
182 SLEEP DISORDER 171
183 DYSPEPSIA 170
184 DEHYDRATION 169
185 EPILEPSY 165
186 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 165
187 ANAPHYLACTIC REACTION 164
188 INFLAMMATION 163
189 GASTROINTESTINAL DISORDER 162
190 PRODUCT TEMPERATURE EXCURSION ISSUE 161
191 SWELLING OF EYELID 161
192 LETHARGY 160
193 MUSCLE ATROPHY 160
194 HERPES ZOSTER 157
195 EYE PRURITUS 151
196 MULTIPLE SCLEROSIS RELAPSE 151
197 MUSCLE SPASTICITY 151
198 POOR QUALITY DRUG ADMINISTERED 151
199 TACHYCARDIA 150
200 CHOKING 149
201 RHEUMATOID ARTHRITIS 149
202 FIBROMYALGIA 147
203 LYMPHADENOPATHY 147
204 APHASIA 146
205 GAIT INABILITY 146
206 ROAD TRAFFIC ACCIDENT 146
207 DISTURBANCE IN ATTENTION 143
208 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 143
209 SENSORY DISTURBANCE 143
210 DRUG RESISTANCE 142
211 THROAT IRRITATION 142
212 ACNE 140
213 BRONCHITIS 138
214 IMPAIRED WORK ABILITY 138
215 RASH ERYTHEMATOUS 138
216 UPPER RESPIRATORY TRACT INFECTION 137
217 INTENTIONAL PRODUCT USE ISSUE 134
218 NEUROPATHY PERIPHERAL 134
219 INJECTION SITE NODULE 133
220 ASTHENOPIA 132
221 BLISTER 131
222 PRODUCT DISTRIBUTION ISSUE 130
223 RASH PAPULAR 130
224 SEPSIS 130
225 ABDOMINAL DISTENSION 128
226 EAR PAIN 127
227 INJECTION SITE DISCOMFORT 127
228 MASS 127
229 RHINORRHOEA 127
230 SWOLLEN TONGUE 127
231 NERVE INJURY 126
232 GENERAL PHYSICAL HEALTH DETERIORATION 125
233 BLINDNESS 123
234 DRY SKIN 123
235 TENSION HEADACHE 123
236 VISUAL ACUITY REDUCED 123
237 DRUG INTERACTION 122
238 MOVEMENT DISORDER 122
239 NASAL CONGESTION 122
240 CELLULITIS 121
241 MASTICATION DISORDER 121
242 BRAIN FOG 120
243 COGNITIVE DISORDER 120
244 EXPOSURE DURING PREGNANCY 120
245 PERIORBITAL OEDEMA 120
246 CYSTITIS 119
247 DYSSTASIA 119
248 OCULAR DISCOMFORT 119
249 RESPIRATORY DISORDER 116
250 CARDIAC DISORDER 115
251 DEVICE DIFFICULT TO USE 115
252 DYSURIA 114
253 DRUG EFFECT INCOMPLETE 113
254 HALLUCINATION 113
255 SYSTEMIC LUPUS ERYTHEMATOSUS 113
256 EAR DISCOMFORT 112
257 HOT FLUSH 112
258 INFUSION RELATED REACTION 112
259 WHEEZING 111
260 NIGHT SWEATS 110
261 ARTHRITIS 109
262 OEDEMA PERIPHERAL 109
263 PRESYNCOPE 109
264 DISORIENTATION 108
265 HAEMORRHAGE 108
266 JOINT SWELLING 108
267 BLOOD PRESSURE DECREASED 107
268 INTENTIONAL PRODUCT MISUSE 107
269 NEOPLASM MALIGNANT 107
270 OSTEOARTHRITIS 105
271 THERAPY CESSATION 105
272 DRUG EFFECT DECREASED 104
273 RASH PRURITIC 104
274 SKIN BURNING SENSATION 104
275 ANAEMIA 103
276 DEPRESSED MOOD 103
277 FOETAL EXPOSURE DURING PREGNANCY 103
278 NERVOUS SYSTEM DISORDER 103
279 TOXICITY TO VARIOUS AGENTS 103
280 HEAD INJURY 102
281 LIVE BIRTH 102
282 RESPIRATORY FAILURE 102
283 VIITH NERVE PARALYSIS 102
284 EYE DISCHARGE 101
285 ABORTION SPONTANEOUS 100
286 ARTHROPATHY 100
287 NERVOUSNESS 100
288 PNEUMONIA ASPIRATION 100
289 SKIN EXFOLIATION 100
290 POLLAKIURIA 99
291 MYOCARDIAL INFARCTION 98
292 DRUG DOSE OMISSION BY DEVICE 97
293 INJECTION SITE HAEMATOMA 97
294 PSORIATIC ARTHROPATHY 97
295 BREAST CANCER 96
296 EMOTIONAL DISTRESS 96
297 PRODUCT DOSE OMISSION 96
298 STOMATITIS 96
299 TASTE DISORDER 96
300 VIRAL INFECTION 96
301 NODULE 95
302 THERAPY INTERRUPTED 95
303 DRUG ADMINISTERED AT INAPPROPRIATE SITE 94
304 INJURY 94
305 IRRITABILITY 94
306 MUSCULOSKELETAL DISORDER 93
307 FEEDING DISORDER 92
308 PARAESTHESIA ORAL 92
309 UNDERDOSE 92
310 CATARACT 91
311 MUSCULOSKELETAL DISCOMFORT 91
312 PRODUCT DISPENSING ERROR 91
313 CONCUSSION 90
314 LIMB DISCOMFORT 90
315 PALLOR 88
316 TORTICOLLIS 88
317 ATRIAL FIBRILLATION 87
318 DYSTONIA 87
319 WOUND 87
320 CONTRAINDICATED PRODUCT ADMINISTERED 85
321 JOINT RANGE OF MOTION DECREASED 85
322 PULMONARY EMBOLISM 85
323 DROOLING 84
324 CRYING 83
325 FACE OEDEMA 83
326 INJECTION SITE OEDEMA 83
327 LAGOPHTHALMOS 83
328 IMPAIRED DRIVING ABILITY 82
329 JOINT STIFFNESS 82
330 OEDEMA 82
331 BLOOD CHOLESTEROL INCREASED 81
332 EYELID DISORDER 81
333 HYPOACUSIS 81
334 PHARYNGEAL OEDEMA 81
335 POOR QUALITY SLEEP 81
336 PRODUCT ADMINISTRATION ERROR 81
337 SINUS DISORDER 81
338 HYPOTONIA 80
339 INCORRECT PRODUCT STORAGE 80
340 IRRITABLE BOWEL SYNDROME 80
341 MADAROSIS 80
342 CONVULSION 79
343 DEVICE ISSUE 79
344 DRUG DOSE OMISSION 79
345 INJECTION SITE PAPULE 79
346 BONE PAIN 78
347 MUSCLE DISORDER 78
348 SPINAL OPERATION 78
349 SYNOVITIS 78
350 TENDERNESS 78
351 APHONIA 77
352 FACIAL SPASM 77
353 EAR INFECTION 76
354 TYPE 2 DIABETES MELLITUS 76
355 WHITE BLOOD CELL COUNT DECREASED 76
356 EYELID SENSORY DISORDER 75
357 INJECTION SITE DISCOLOURATION 75
358 TRANSIENT ISCHAEMIC ATTACK 75
359 OXYGEN SATURATION DECREASED 74
360 PRODUCTIVE COUGH 74
361 RESPIRATORY TRACT INFECTION 73
362 PERICARDITIS 72
363 PRODUCT COMPLAINT 72
364 SCAR 72
365 TRISMUS 72
366 DRUG EFFECT LESS THAN EXPECTED 71
367 FEELING COLD 71
368 NO ADVERSE EVENT 71
369 PRESCRIBED OVERDOSE 71
370 SLEEP APNOEA SYNDROME 71
371 THROMBOSIS 71
372 ASPIRATION 70
373 EXPIRED PRODUCT ADMINISTERED 70
374 MENTAL IMPAIRMENT 70
375 PRODUCT PHYSICAL ISSUE 70
376 ABNORMAL SENSATION IN EYE 69
377 EYE MOVEMENT DISORDER 69
378 ILL-DEFINED DISORDER 69
379 INTERVERTEBRAL DISC PROTRUSION 69
380 PAIN OF SKIN 69
381 TOOTHACHE 69
382 C-REACTIVE PROTEIN INCREASED 68
383 OSTEOPOROSIS 68
384 SNEEZING 68
385 ANGIOEDEMA 67
386 DEAFNESS 67
387 IMPAIRED GASTRIC EMPTYING 67
388 INJECTION SITE WARMTH 67
389 MYDRIASIS 67
390 POST PROCEDURAL COMPLICATION 67
391 POSTURE ABNORMAL 67
392 AGITATION 66
393 GENERAL PHYSICAL CONDITION ABNORMAL 66
394 HEMIPARESIS 66
395 HYPOTHYROIDISM 66
396 MICTURITION URGENCY 66
397 ACTIVITIES OF DAILY LIVING IMPAIRED 65
398 AGEUSIA 65
399 CROHN^S DISEASE 65
400 DISABILITY 65
401 ONYCHOMADESIS 65
402 AUTOIMMUNE DISORDER 64
403 BODY TEMPERATURE INCREASED 64
404 EYE CONTUSION 64
405 INJECTION SITE INFLAMMATION 64
406 PRURITUS GENERALISED 64
407 SENSATION OF FOREIGN BODY 64
408 EATING DISORDER 63
409 INSURANCE ISSUE 63
410 JOINT DISLOCATION 63
411 LUNG DISORDER 63
412 MEDICATION ERROR 63
413 MIDDLE INSOMNIA 63
414 RASH GENERALISED 63
415 RIB FRACTURE 63
416 INCORRECT ROUTE OF DRUG ADMINISTRATION 62
417 BLADDER DISORDER 61
418 HEPATIC ENZYME INCREASED 61
419 MENTAL DISORDER 61
420 PSORIASIS 61
421 TRIGEMINAL NEURALGIA 61
422 WOUND INFECTION 61
423 BLOOD GLUCOSE INCREASED 60
424 FACIAL DISCOMFORT 60
425 FEAR 60
426 PEMPHIGUS 60
427 HEART RATE DECREASED 59
428 MYASTHENIA GRAVIS 59
429 PHOTOSENSITIVITY REACTION 59
430 FACIAL PALSY 58
431 RASH MACULAR 58
432 VITREOUS FLOATERS 58
433 ARRHYTHMIA 57
434 FUNGAL INFECTION 57
435 LARYNGITIS 57
436 LIMB INJURY 57
437 COLD SWEAT 56
438 ECZEMA 56
439 HYPERACUSIS 56
440 LIP DISORDER 56
441 HYPOKINESIA 55
442 INJECTION SITE HYPOAESTHESIA 55
443 RESTLESS LEGS SYNDROME 55
444 EMOTIONAL DISORDER 54
445 EPISTAXIS 54
446 HEART RATE IRREGULAR 54
447 INCORRECT PRODUCT FORMULATION ADMINISTERED 54
448 LOWER RESPIRATORY TRACT INFECTION 54
449 BEDRIDDEN 53
450 DIABETES MELLITUS 53
451 FLUID RETENTION 53
452 HYPERSOMNIA 53
453 KIDNEY INFECTION 53
454 LOCAL SWELLING 53
455 SEASONAL ALLERGY 53
456 SINUS CONGESTION 53
457 STRABISMUS 53
458 WHITE BLOOD CELL COUNT INCREASED 53
459 ABASIA 52
460 ADVERSE REACTION 52
461 MEPHISTO SIGN 52
462 PRE-EXISTING CONDITION IMPROVED 52
463 PRODUCT CONTAINER ISSUE 52
464 SKIN MASS 52
465 BELL^S PALSY 51
466 BURSITIS 51
467 DEVICE MALFUNCTION 51
468 EYE INFECTION 51
469 IMPAIRED HEALING 51
470 OCCUPATIONAL EXPOSURE TO PRODUCT 51
471 SKIN IRRITATION 51
472 THINKING ABNORMAL 51
473 ANAPHYLACTIC SHOCK 50
474 BRAIN INJURY 50
475 CARDIAC ARREST 50
476 DEFORMITY 50
477 HYPOAESTHESIA FACIAL 50
478 IMPAIRED QUALITY OF LIFE 50
479 INCONTINENCE 50
480 PHARYNGEAL SWELLING 50
481 RHEUMATIC FEVER 50
482 SUSPECTED COUNTERFEIT PRODUCT 50
483 THERAPEUTIC PRODUCT EFFECT VARIABLE 50
484 ANGINA PECTORIS 49
485 CHOKING SENSATION 49
486 CONJUNCTIVITIS 49
487 PANIC REACTION 49
488 PRODUCT ADMINISTRATION INTERRUPTED 49
489 PRODUCT PACKAGING QUANTITY ISSUE 49
490 PRODUCT SUPPLY ISSUE 49
491 SALIVARY HYPERSECRETION 49
492 SPINAL PAIN 49
493 GRIP STRENGTH DECREASED 48
494 HAEMATOMA 48
495 HYPERAESTHESIA 48
496 INJECTION SITE INDURATION 48
497 INJECTION SITE PARAESTHESIA 48
498 MUSCLE STRAIN 48
499 SKIN HYPERPIGMENTATION 48
500 STAPHYLOCOCCAL INFECTION 48
501 ANOSMIA 47
502 ERYTHEMA OF EYELID 47
503 OPHTHALMOPLEGIA 47
504 ORAL DISCOMFORT 47
505 WITHDRAWAL SYNDROME 47
506 BACK INJURY 46
507 BLINDNESS UNILATERAL 46
508 BLOOD POTASSIUM DECREASED 46
509 DIVERTICULITIS 46
510 FOREIGN BODY SENSATION IN EYES 46
511 HAEMATURIA 46
512 RENAL DISORDER 46
513 RENAL FAILURE 46
514 THIRST 46
515 VISUAL FIELD DEFECT 46
516 CHOLELITHIASIS 45
517 COLITIS ULCERATIVE 45
518 DEEP VEIN THROMBOSIS 45
519 DEPRESSED LEVEL OF CONSCIOUSNESS 45
520 DERMATITIS CONTACT 45
521 GLOSSODYNIA 45
522 GUILLAIN-BARRE SYNDROME 45
523 HAEMORRHOIDS 45
524 HYPOPHAGIA 45
525 INJECTION SITE VESICLES 45
526 INTESTINAL OBSTRUCTION 45
527 MUSCLE CONTRACTIONS INVOLUNTARY 45
528 ONYCHOMYCOSIS 45
529 ORAL HERPES 45
530 ORAL PAIN 45
531 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 45
532 INJECTION SITE IRRITATION 44
533 RECTAL HAEMORRHAGE 44
534 RETCHING 44
535 TOOTH DISORDER 44
536 BLADDER SPASM 43
537 DERMATITIS 43
538 DRY THROAT 43
539 HAEMOGLOBIN DECREASED 43
540 HYPERTONIC BLADDER 43
541 KNEE ARTHROPLASTY 43
542 LOWER LIMB FRACTURE 43
543 MUSCLE RIGIDITY 43
544 PARANASAL SINUS DISCOMFORT 43
545 SCIATICA 43
546 SKIN INDENTATION 43
547 APPLICATION SITE PAIN 42
548 CEREBRAL HAEMORRHAGE 42
549 MOOD ALTERED 42
550 PATIENT DISSATISFACTION WITH TREATMENT 42
551 PRODUCT PACKAGING ISSUE 42
552 SKIN LESION 42
553 THERAPY PARTIAL RESPONDER 42
554 BRUXISM 41
555 CARPAL TUNNEL SYNDROME 41
556 COMA 41
557 ELECTRIC SHOCK SENSATION 41
558 POST-TRAUMATIC NECK SYNDROME 41
559 PROCEDURAL PAIN 41
560 RESPIRATORY TRACT CONGESTION 41
561 SENSORY LOSS 41
562 SUSPECTED PRODUCT QUALITY ISSUE 41
563 THERAPEUTIC RESPONSE DELAYED 41
564 ACUTE KIDNEY INJURY 40
565 BACK DISORDER 40
566 FLATULENCE 40
567 FOOT FRACTURE 40
568 HIP FRACTURE 40
569 INTENTIONAL DOSE OMISSION 40
570 MOTOR DYSFUNCTION 40
571 MUSCLE INJURY 40
572 PARKINSON^S DISEASE 40
573 SENSATION OF HEAVINESS 40
574 TONGUE DISORDER 40
575 ALANINE AMINOTRANSFERASE INCREASED 39
576 ANGER 39
577 CYST 39
578 DRUG ABUSE 39
579 FACET JOINT SYNDROME 39
580 IMMUNE SYSTEM DISORDER 39
581 INCORRECT DOSE ADMINISTERED BY DEVICE 39
582 JOINT INJURY 39
583 MONOPLEGIA 39
584 PELVIC PAIN 39
585 PREMATURE BABY 39
586 RAYNAUD^S PHENOMENON 39
587 SECRETION DISCHARGE 39
588 SINUS HEADACHE 39
589 BLINDNESS TRANSIENT 38
590 BRADYCARDIA 38
591 BREAST CANCER FEMALE 38
592 CEREBRAL INFARCTION 38
593 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 38
594 OROPHARYNGEAL DISCOMFORT 38
595 PAROSMIA 38
596 RED BLOOD CELL SEDIMENTATION RATE INCREASED 38
597 RESPIRATORY DISTRESS 38
598 THERAPEUTIC PRODUCT EFFECT DELAYED 38
599 DELIRIUM 37
600 DEMENTIA 37
601 DRUG WITHDRAWAL SYNDROME 37
602 FOLLICULITIS 37
603 FREQUENT BOWEL MOVEMENTS 37
604 GLAUCOMA 37
605 HYSTERECTOMY 37
606 INITIAL INSOMNIA 37
607 LIP DRY 37
608 LIVER FUNCTION TEST INCREASED 37
609 RESPIRATORY ARREST 37
610 SPINAL OSTEOARTHRITIS 37
611 ANAL INCONTINENCE 36
612 CARDIAC FAILURE 36
613 DERMATITIS ATOPIC 36
614 EXOSTOSIS 36
615 FOOD ALLERGY 36
616 INFUSION SITE PAIN 36
617 MUSCLE FATIGUE 36
618 PERIPHERAL COLDNESS 36
619 PERONEAL NERVE PALSY 36
620 SCAB 36
621 SEPTIC SHOCK 36
622 TEMPOROMANDIBULAR JOINT SYNDROME 36
623 ABNORMAL BEHAVIOUR 35
624 BLADDER PAIN 35
625 CHRONIC KIDNEY DISEASE 35
626 DEAFNESS UNILATERAL 35
627 GASTRITIS 35
628 GASTROENTERITIS VIRAL 35
629 GENERALISED TONIC-CLONIC SEIZURE 35
630 INJECTION SITE INDENTATION 35
631 NEUROMUSCULAR TOXICITY 35
632 PAPULE 35
633 PNEUMOTHORAX 35
634 PRODUCT USED FOR UNKNOWN INDICATION 35
635 TEMPERATURE INTOLERANCE 35
636 UNRESPONSIVE TO STIMULI 35
637 DUODENAL ULCER PERFORATION 34
638 FOOT DEFORMITY 34
639 INTERVERTEBRAL DISC DEGENERATION 34
640 JAW DISORDER 34
641 LID SULCUS DEEPENED 34
642 MATERNAL EXPOSURE DURING BREAST FEEDING 34
643 PERIPHERAL VENOUS DISEASE 34
644 PHOTOPSIA 34
645 CANDIDA INFECTION 33
646 EYELID FUNCTION DISORDER 33
647 GASTRIC DISORDER 33
648 HERNIA 33
649 HYPONATRAEMIA 33
650 INJURY ASSOCIATED WITH DEVICE 33
651 LYMPHOCYTE COUNT DECREASED 33
652 MOUTH SWELLING 33
653 NEUROLOGICAL SYMPTOM 33
654 PERSONALITY DISORDER 33
655 POST-TRAUMATIC STRESS DISORDER 33
656 SKIN LACERATION 33
657 APPLICATION SITE ERYTHEMA 32
658 HYPERTONIA 32
659 LIBIDO INCREASED 32
660 LIVER DISORDER 32
661 MOUTH ULCERATION 32
662 MUSCULOSKELETAL CHEST PAIN 32
663 NERVE COMPRESSION 32
664 PANCREATITIS 32
665 PHARYNGEAL HYPOAESTHESIA 32
666 PRESCRIBED UNDERDOSE 32
667 RESTLESSNESS 32
668 SOFT TISSUE INJURY 32
669 ABNORMAL DREAMS 31
670 BACTERIAL INFECTION 31
671 BIPOLAR DISORDER 31
672 BLOOD CREATINE PHOSPHOKINASE INCREASED 31
673 BLOOD PRESSURE FLUCTUATION 31
674 BLOOD URINE PRESENT 31
675 CHOLECYSTECTOMY 31
676 DRUG ERUPTION 31
677 DRUG SPECIFIC ANTIBODY PRESENT 31
678 DYSGRAPHIA 31
679 DYSPNOEA EXERTIONAL 31
680 EYELID PAIN 31
681 HOSTILITY 31
682 IMMUNODEFICIENCY 31
683 INJECTION SITE HYPERSENSITIVITY 31
684 MIGRAINE WITH AURA 31
685 OBESITY 31
686 STERNAL FRACTURE 31
687 THYROID DISORDER 31
688 TOOTH FRACTURE 31
689 UPPER LIMB FRACTURE 31
690 WRONG PRODUCT ADMINISTERED 31
691 BRAIN NEOPLASM 30
692 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30
693 DEVICE DISLOCATION 30
694 NASAL DISCOMFORT 30
695 NYSTAGMUS 30
696 POSTNATAL GROWTH RESTRICTION 30
697 RHEUMATOID FACTOR POSITIVE 30
698 SKIN INFECTION 30
699 SPINAL FUSION SURGERY 30
700 SWOLLEN JOINT COUNT INCREASED 30
701 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 29
702 BLOOD CREATININE INCREASED 29
703 BREAST CANCER STAGE III 29
704 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29
705 EYE INFLAMMATION 29
706 FEELING DRUNK 29
707 FEMUR FRACTURE 29
708 HYPOKALAEMIA 29
709 INJECTION SITE INFECTION 29
710 LOCALISED INFECTION 29
711 MULTIPLE ALLERGIES 29
712 NEEDLE ISSUE 29
713 PARTIAL SEIZURES 29
714 SKIN WARM 29
715 TENDONITIS 29
716 UPPER-AIRWAY COUGH SYNDROME 29
717 VOCAL CORD PARALYSIS 29
718 WEIGHT FLUCTUATION 29
719 ARTHROPOD BITE 28
720 BLOOD GLUCOSE DECREASED 28
721 BLOOD PRESSURE ABNORMAL 28
722 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28
723 COUNTERFEIT PRODUCT ADMINISTERED 28
724 DERMATITIS ALLERGIC 28
725 DEVICE BREAKAGE 28
726 DIZZINESS POSTURAL 28
727 ECONOMIC PROBLEM 28
728 FEELING JITTERY 28
729 FORMICATION 28
730 GESTATIONAL HYPERTENSION 28
731 HERPES VIRUS INFECTION 28
732 HYPERCHOLESTEROLAEMIA 28
733 HYPOAESTHESIA EYE 28
734 INJECTION SITE SCAR 28
735 OCCIPITAL NEURALGIA 28
736 ORAL DISORDER 28
737 RASH VESICULAR 28
738 SKIN SWELLING 28
739 SPINAL FRACTURE 28
740 TARDIVE DYSKINESIA 28
741 VITAMIN D DEFICIENCY 28
742 ALTERED STATE OF CONSCIOUSNESS 27
743 ATAXIA 27
744 CARDIO-RESPIRATORY ARREST 27
745 HEPATIC FUNCTION ABNORMAL 27
746 HYPOGLYCAEMIA 27
747 LACERATION 27
748 MOOD SWINGS 27
749 POST PROCEDURAL INFECTION 27
750 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 27
751 TOOTH INFECTION 27
752 TREATMENT NONCOMPLIANCE 27
753 ACCIDENT 26
754 BLEPHARITIS 26
755 CARDIAC FAILURE CONGESTIVE 26
756 CYSTITIS NONINFECTIVE 26
757 DARK CIRCLES UNDER EYES 26
758 DRUG ADMINISTRATION ERROR 26
759 ENDOMETRIOSIS 26
760 GASTRIC ULCER 26
761 HEMIPLEGIA 26
762 HIATUS HERNIA 26
763 HORDEOLUM 26
764 KNEE OPERATION 26
765 LIP PAIN 26
766 NECK SURGERY 26
767 ODYNOPHAGIA 26
768 QUALITY OF LIFE DECREASED 26
769 VAGINAL HAEMORRHAGE 26
770 AUTONOMIC NERVOUS SYSTEM IMBALANCE 25
771 CENTRAL NERVOUS SYSTEM LESION 25
772 CLOSTRIDIUM DIFFICILE INFECTION 25
773 COORDINATION ABNORMAL 25
774 CYANOSIS 25
775 DENTAL CARIES 25
776 DISEASE PROGRESSION 25
777 DRUG DEPENDENCE 25
778 DRUG TOLERANCE 25
779 EYE INJURY 25
780 HELICOBACTER INFECTION 25
781 INJECTION SITE INJURY 25
782 LEUKOPENIA 25
783 LIGAMENT SPRAIN 25
784 LIVER INJURY 25
785 NEUROGENIC BLADDER 25
786 OBSTRUCTIVE AIRWAYS DISORDER 25
787 ON AND OFF PHENOMENON 25
788 PLEURAL EFFUSION 25
789 PRODUCT AVAILABILITY ISSUE 25
790 RENAL PAIN 25
791 ROTATOR CUFF SYNDROME 25
792 SKIN ATROPHY 25
793 SKIN CANCER 25
794 SPINAL STENOSIS 25
795 ULCER 25
796 APPLICATION SITE PRURITUS 24
797 CERVICOGENIC HEADACHE 24
798 EYE OPERATION 24
799 FRACTURE 24
800 GINGIVAL PAIN 24
801 HYDROCEPHALUS 24
802 IMMUNOSUPPRESSION 24
803 INCREASED TENDENCY TO BRUISE 24
804 LABORATORY TEST ABNORMAL 24
805 LIQUID PRODUCT PHYSICAL ISSUE 24
806 MENSTRUAL DISORDER 24
807 NAIL DISORDER 24
808 PLATELET COUNT DECREASED 24
809 PROCEDURAL COMPLICATION 24
810 PRODUCT LABEL ISSUE 24
811 PULMONARY FIBROSIS 24
812 RED BLOOD CELL COUNT DECREASED 24
813 RETINAL DETACHMENT 24
814 RHABDOMYOLYSIS 24
815 SKIN REACTION 24
816 TOOTH LOSS 24
817 URINARY BLADDER HAEMORRHAGE 24
818 AUTOIMMUNE THYROIDITIS 23
819 CEREBRAL DISORDER 23
820 COLITIS 23
821 EXPOSURE VIA SKIN CONTACT 23
822 EYE HAEMORRHAGE 23
823 EYE OEDEMA 23
824 FINE MOTOR SKILL DYSFUNCTION 23
825 GASTROINTESTINAL MOTILITY DISORDER 23
826 HAND DEFORMITY 23
827 IRON DEFICIENCY ANAEMIA 23
828 LIMB OPERATION 23
829 MUSCLE HYPERTROPHY 23
830 MYOSITIS 23
831 PRODUCT CONTAMINATION 23
832 PRODUCT DOSE OMISSION IN ERROR 23
833 PRODUCT PRESCRIBING ISSUE 23
834 PRODUCT SUBSTITUTION ISSUE 23
835 PRODUCT USE COMPLAINT 23
836 PSYCHOTIC DISORDER 23
837 REDUCED FACIAL EXPRESSION 23
838 RENAL IMPAIRMENT 23
839 SHOULDER OPERATION 23
840 SKIN ODOUR ABNORMAL 23
841 SKIN ULCER 23
842 TENSION 23
843 ABDOMINAL PAIN LOWER 22
844 AGGRESSION 22
845 ANKLE FRACTURE 22
846 CARDIOVASCULAR DISORDER 22
847 DECUBITUS ULCER 22
848 EXTRAOCULAR MUSCLE PARESIS 22
849 EYELIDS PRURITUS 22
850 FACE INJURY 22
851 GASTROINTESTINAL PAIN 22
852 HAEMATOCHEZIA 22
853 HAIR TEXTURE ABNORMAL 22
854 HYPOXIA 22
855 INJECTION RELATED REACTION 22
856 INJECTION SITE EXTRAVASATION 22
857 MACULAR DEGENERATION 22
858 MENTAL STATUS CHANGES 22
859 MIGRAINE WITHOUT AURA 22
860 MYOCLONUS 22
861 OSTEOMYELITIS 22
862 PHARYNGITIS 22
863 PHYSICAL DECONDITIONING 22
864 POISONING 22
865 PRODUCT PRESCRIBING ERROR 22
866 SENSATION OF PRESSURE 22
867 SUDDEN DEATH 22
868 VOCAL CORD DISORDER 22
869 APNOEA 21
870 ASPARTATE AMINOTRANSFERASE INCREASED 21
871 ASPHYXIA 21
872 ATROPHY 21
873 AURA 21
874 CUTIS LAXA 21
875 DYSPHEMIA 21
876 FOOD POISONING 21
877 GALLBLADDER OPERATION 21
878 GESTATIONAL DIABETES 21
879 HAEMORRHAGE SUBCUTANEOUS 21
880 HIP ARTHROPLASTY 21
881 HORMONE LEVEL ABNORMAL 21
882 HYPERLIPIDAEMIA 21
883 HYPERVENTILATION 21
884 INCREASED UPPER AIRWAY SECRETION 21
885 INTERNAL HAEMORRHAGE 21
886 INTRACRANIAL PRESSURE INCREASED 21
887 MALNUTRITION 21
888 MAST CELL ACTIVATION SYNDROME 21
889 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21
890 NEOPLASM 21
891 NO THERAPEUTIC RESPONSE 21
892 NOCTURIA 21
893 NONSPECIFIC REACTION 21
894 OESOPHAGEAL DISORDER 21
895 OPTIC NEURITIS 21
896 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 21
897 PULMONARY OEDEMA 21
898 RESIDUAL URINE VOLUME INCREASED 21
899 ROSACEA 21
900 SCOLIOSIS 21
901 SKIN HAEMORRHAGE 21
902 SKIN LAXITY 21
903 THERAPY CHANGE 21
904 VENTRICULAR EXTRASYSTOLES 21
905 ABSCESS 20
906 ACUTE RESPIRATORY FAILURE 20
907 APPENDICITIS 20
908 C-REACTIVE PROTEIN ABNORMAL 20
909 DYSMENORRHOEA 20
910 EXTRA DOSE ADMINISTERED 20
911 FACE LIFT 20
912 FAECAL INCONTINENCE 20
913 FEELING OF BODY TEMPERATURE CHANGE 20
914 FRUSTRATION TOLERANCE DECREASED 20
915 GENERAL SYMPTOM 20
916 INFUSION SITE REACTION 20
917 MALABSORPTION 20
918 MANUFACTURING PRODUCT SHIPPING ISSUE 20
919 PHARYNGITIS STREPTOCOCCAL 20
920 PROCTALGIA 20
921 SLUGGISHNESS 20
922 SUICIDE ATTEMPT 20
923 TERMINAL INSOMNIA 20
924 VITAMIN D DECREASED 20
925 WALKING AID USER 20
926 AMYOTROPHIC LATERAL SCLEROSIS 19
927 AREFLEXIA 19
928 CHEILITIS 19
929 DRUG TOXICITY 19
930 EXCESSIVE EYE BLINKING 19
931 GALLBLADDER DISORDER 19
932 GASTROENTERITIS 19
933 HALLUCINATION, VISUAL 19
934 HUNGER 19
935 ILEUS PARALYTIC 19
936 INTERVERTEBRAL DISC DISORDER 19
937 MENISCUS INJURY 19
938 NASAL DRYNESS 19
939 NASAL OEDEMA 19
940 PARANOIA 19
941 PINEAL GLAND CYST 19
942 PRODUCT TASTE ABNORMAL 19
943 PULMONARY CONGESTION 19
944 RASH PUSTULAR 19
945 RHINALGIA 19
946 RHINITIS 19
947 SJOGREN^S SYNDROME 19
948 SKIN FISSURES 19
949 STATUS EPILEPTICUS 19
950 THERMAL BURN 19
951 TONGUE MOVEMENT DISTURBANCE 19
952 TONGUE PARALYSIS 19
953 VEIN DISORDER 19
954 WRIST FRACTURE 19
955 ABORTION INDUCED 18
956 ANTINUCLEAR ANTIBODY POSITIVE 18
957 BRONCHIECTASIS 18
958 CIRCULATORY COLLAPSE 18
959 DECREASED ACTIVITY 18
960 DEVICE USE ERROR 18
961 DROPPED HEAD SYNDROME 18
962 ENDOMETRIAL CANCER 18
963 ERUCTATION 18
964 FLUID INTAKE REDUCED 18
965 HEPATIC CIRRHOSIS 18
966 HYPOPNOEA 18
967 INCORRECT STORAGE OF DRUG 18
968 INFUSION SITE BRUISING 18
969 INFUSION SITE SWELLING 18
970 LUMBAR SPINAL STENOSIS 18
971 LUPUS-LIKE SYNDROME 18
972 PARESIS 18
973 PHARYNGEAL DISORDER 18
974 PREMATURE LABOUR 18
975 SEROTONIN SYNDROME 18
976 VASODILATATION 18
977 VESTIBULAR MIGRAINE 18
978 WHEELCHAIR USER 18
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 18
980 APPLICATION SITE VESICLES 17
981 AUTONOMIC DYSREFLEXIA 17
982 BOWEL MOVEMENT IRREGULARITY 17
983 BRADYKINESIA 17
984 CHROMATURIA 17
985 COMPLICATION ASSOCIATED WITH DEVICE 17
986 CRANIOCEREBRAL INJURY 17
987 DEEP VEIN THROMBOSIS POSTOPERATIVE 17
988 DRUG EXPOSURE DURING PREGNANCY 17
989 ECCHYMOSIS 17
990 EXOPHTHALMOS 17
991 EXPOSURE VIA BREAST MILK 17
992 EXTRAPYRAMIDAL DISORDER 17
993 EYELID IRRITATION 17
994 FEELING OF DESPAIR 17
995 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17
996 GASTROINTESTINAL INFECTION 17
997 GRAND MAL CONVULSION 17
998 HAEMATOCRIT DECREASED 17
999 HEAD TITUBATION 17